Economics ❯ Market Transactions
Pharmaceutical Investments Corporate Strategy Bidding Process Agricultural Investments Private Investors Corporate Acquisitions Asset Management
The phased deal leaves Equinor as a non‑operated 20% partner pending a second closing targeted for mid‑2026.
